Haemonetics Corporation Stock Prediction
AI-powered sentiment analysis and prediction trends for HAE, updated each market day.
HAE AI Sentiment
AI sees no strong directional signal for Haemonetics Corporation stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Sector
Exchange
Market Cap
$4,895,482,687
Cap Tier
Employees
3,009
Headquarters
BOSTON, MA
Listed Since
May 9, 1991
Website
HAE Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
HAE Volatility
Haemonetics Corporation has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
